GSK, Merck and Indian firms slash childhood vaccine prices for GAVI/UNICEF
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline, Merck and several Indian firms have cut the prices of their essential life-saving vaccines so they can be procured for poor children in least developed countries at affordable prices. The price reduction deal, announced by the vaccine-funder GAVI Alliance (vaccines are procured through UNICEF), includes pentavalent, rotavirus and human papillomavirus (HPV) vaccines (see table below).